Ablative Solutions, Inc. was founded with a vision to address the unmet need of hypertension. Ablative Solutions' approach targets the overactive sympathetic nervous system, which may play a role in hypertension, heart failure, kidney disease, metabolic syndrome and sleep apnea.
United States of America
- (20.Feb.2020) Ablative Solutions Announces Publication of Data From the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
- (03.Sep.2019) Ablative Solutions Announces Positive 12-Month Results From Study Evaluating Company's Novel Therapy for Uncontrolled Hypertension